Entity Common Stock, Shares Outstanding of Hepion Pharmaceuticals, Inc. from 04 Feb 2014 to 12 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Hepion Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 04 Feb 2014 to 12 Nov 2025.
  • Hepion Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 12 Nov 2025 was 11,620,317, a 67% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Hepion Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 11,620,317 +4,661,946 +67% 12 Nov 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 11,620,317 +5,821,191 +100% 14 Aug 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 10,975,276 +5,502,150 +101% 08 Apr 2025 10-K 08 Apr 2025 2024 FY
Q3 2024 6,958,371 +2,620,689 +60% 14 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 5,799,126 +1,960,837 +51% 12 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 5,473,126 -70,756,500 -93% 13 Mar 2024 10-K/A 13 Jan 2025 2023 FY
Q3 2023 4,337,682 -71,891,935 -94% 06 Nov 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 3,838,289 -72,391,328 -95% 07 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 76,229,626 +55 0% 23 Mar 2023 10-K 10 Apr 2023 2022 FY
Q3 2022 76,229,617 +4,363 +0.01% 09 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 76,229,617 +4,372 +0.01% 11 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 76,229,571 +4,326 +0.01% 30 Mar 2022 10-K 08 Apr 2022 2021 FY
Q3 2021 76,225,254 +67,200,101 +745% 11 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 76,225,245 +67,200,184 +745% 11 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 76,225,245 +67,200,184 +745% 24 Mar 2021 10-K 31 Mar 2021 2020 FY
Q3 2020 9,025,153 +5,571,398 +161% 10 Nov 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 9,025,061 +5,571,460 +161% 19 Jun 2020 10-Q 29 Jun 2020 2020 Q1
Q1 2020 9,025,061 -8,154,270 -47% 14 May 2020 10-K 14 May 2020 2019 FY
Q3 2019 3,453,755 -12,890,165 -79% 11 Nov 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 3,453,601 -10,998,317 -76% 14 Aug 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 17,179,331 -67,771,881 -80% 12 Mar 2019 10-K 14 Mar 2019 2018 FY
Q3 2018 16,343,920 -61,657,911 -79% 12 Nov 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 14,451,918 09 Aug 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 84,951,212 +21,243,864 +33% 16 Mar 2018 10-KT 26 Mar 2018 2017 FY
Q3 2017 78,001,831 +24,346,149 +45% 15 Sep 2017 10-K 28 Sep 2017 2017 FY
Q1 2017 63,707,348 +31,476,107 +98% 12 Apr 2017 10-Q 12 Apr 2017 2017 Q3
Q4 2016 62,779,667 +35,484,604 +130% 08 Feb 2017 10-Q 14 Feb 2017 2017 Q2
Q3 2016 53,655,682 +31,360,619 +141% 26 Sep 2016 10-K 28 Sep 2016 2016 FY
Q1 2016 32,231,241 +9,957,844 +45% 03 May 2016 10-Q 13 May 2016 2016 Q3
Q4 2015 27,295,063 +5,021,666 +23% 09 Feb 2016 10-Q 12 Feb 2016 2016 Q2
Q3 2015 22,295,063 +21,666 +0.1% 17 Sep 2015 10-K 25 Sep 2015 2015 FY
Q1 2015 22,273,397 +3,794,118 +21% 04 May 2015 10-Q 14 May 2015 2015 Q3
Q4 2014 22,273,397 +3,788,103 +20% 09 Feb 2015 10-Q 12 Feb 2015 2015 Q2
Q3 2014 22,273,397 19 Sep 2014 10-K 29 Sep 2014 2014 FY
Q1 2014 18,479,279 13 May 2014 10-Q 15 May 2014 2014 Q3
Q4 2013 18,485,294 04 Feb 2014 10-Q 05 Feb 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.